INNOPEUTICS

Pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for the treatment of viral and infectious diseases and for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; biotechnological preparations for medical purposes, namely, for the treatment of immunological disorders; pharmaceutical compositions for the treatment of genetic, neurological, cardiovascular, and metabolic diseases; pharmaceuticals for the treatment of neurodegenerative disease, namely, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and neuropathy pain; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of central nervous system diseases